ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1

Xia, Renpeng; Hu, Chonghui; Ye, Yuancheng; Zhang, Xiang; Li, Tingting; He, Rihua; Zheng, Shangyou; Wen, Xiaofeng*; Chen, Rufu*广东省人民医院; 南方医科大学; 汕头大学; 中山大学; 6; 1
International Journal of Oncology2023-4DOI: 10.3892/ijo.2023.5493
2被引7阅读
引用收藏
分享

摘要

DNA double-strand break repair is critically involved in oxaliplatin resistance in pancreatic ductal adenocarcinoma (PDAC). Hepatocyte nuclear factor 1 homeobox A (HNF1A) has received increased attention regarding its role in cancer progression. The present study explored the role of HNF1A in oxaliplatin resistance in PDAC. The results revealed that HNF1A expression was negatively associated with oxaliplatin chemoresistance in PDAC tissues and cell lines. HNF1A inhibition promoted the proliferation, colony formation and stemness of PDAC cells, and suppressed their apoptosis. Furthermore, HNF1A inhibition switched nonhomologous end joining to homologous recombination, thereby enhancing genomic stability and oxaliplatin resistance. Mechanistically, HNF1A transcriptionally activates p53-binding protein 1 (53BP1) expression by directly interacting with the 53BP1 promoter region. Upregulation of HNF1A and 53BP1 induced significant inhibition of PDAC growth and oxaliplatin resistance in patient-derived PDAC xenograft models and orthotopic models. In conclusion, the findings of the present study suggested that HNF1A/53BP1 may be a promising PDAC therapeutic target for overcoming oxaliplatin resistance.

学科与关键词

关键词
PDAChepatocyte nuclear factor 1 homeobox Ap53-binding protein 1chemoresistanceDNA repair
相关
加载中…
  • Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair
    Zhang, Xiang; Zheng, Shangyou; Hu, Chonghui; Li, Guolin; Lin, Hongcao; Xia, Renpeng; Ye, Yuancheng; He, Rihua; Li, Zhihua; Lin, Qing*; Chen, Rufu*; Zhou, Quanbo*Oncogene, 2022, 41(16): 2372-2389.被引 22
  • Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer
    Hu, Wenjun; Lei, Linping; Xie, Xuqin; Huang, Libin; Cui, Qian; Dang, Tang; Liu, Gang Logan; Li, Yuan; Sun, Xiaofeng; Zhou, Zongguang*Cell Death & Disease, 2019, 10: 550.
  • Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma
    Zhao, Tiansuo; Jiang, Tingting; Li, Xiaojia; Chang, Shaofei; Sun, Qihui; Kong, Fanyang; Kong, Xiangyu; Wei, Fang; He, Jie; Hao, Jihui*; Xie, Keping*Clinical Cancer Research, 2023, 29(24): 5183-5195.
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Oncology
发表日期
2023-04
卷期
第 62 卷, 第 4 期
页码
45
DOI
10.3892/ijo.2023.5493
语言
ENGLISH
成果收录
SCIE

作者

  • X

    Xia, Renpeng (第一作者)

    2 · southern med univ · guangdong prov peoples hosp

  • H

    Hu, Chonghui

    guangdong prov peoples hosp · southern med univ

查看全部 9 位作者收起作者
  • Y

    Ye, Yuancheng

    2 · southern med univ · guangdong prov peoples hosp

  • Z

    Zhang, Xiang

    1 · sun yat sen univ

  • L

    Li, Tingting

  • H

    He, Rihua

    shantou univ · guangdong prov peoples hosp · southern med univ

  • Z

    Zheng, Shangyou

    guangdong prov peoples hosp · southern med univ

  • W

    Wen, Xiaofeng (通讯)

    6 · sun yat sen univ

  • C

    Chen, Rufu (通讯)

    2 · southern med univ · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417